184 related articles for article (PubMed ID: 35347542)
1. Farnesoid X receptor functions in cervical cancer via the p14
Huang X; Wang B; Shen H; Huang D; Shi G
Mol Biol Rep; 2022 May; 49(5):3617-3625. PubMed ID: 35347542
[TBL] [Abstract][Full Text] [Related]
2. The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation.
Huang X; Wang B; Chen R; Zhong S; Gao F; Zhang Y; Niu Y; Li C; Shi G
Front Cell Dev Biol; 2021; 9():583146. PubMed ID: 33889569
[TBL] [Abstract][Full Text] [Related]
3. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
[TBL] [Abstract][Full Text] [Related]
5. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.
Carr J; Bell E; Pearson AD; Kees UR; Beris H; Lunec J; Tweddle DA
Cancer Res; 2006 Feb; 66(4):2138-45. PubMed ID: 16489014
[TBL] [Abstract][Full Text] [Related]
8. p14(ARF) inhibits the functions of adenovirus E1A oncoprotein.
Shen J; Zhang S; Li Y; Zhang W; Chen J; Zhang M; Wang T; Jiang L; Zou X; Wong J; Li X; Cui Y; Wang C
Biochem J; 2011 Mar; 434(2):275-85. PubMed ID: 21133853
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CCDC69 activates p14
Cui L; Zhou F; Chen C; Wang CC
J Ovarian Res; 2019 Jan; 12(1):4. PubMed ID: 30651135
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors.
Eymin B; Gazzeri S; Brambilla C; Brambilla E
Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548
[TBL] [Abstract][Full Text] [Related]
11. MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63.
Gamble LD; Kees UR; Tweddle DA; Lunec J
Oncogene; 2012 Feb; 31(6):752-63. PubMed ID: 21725357
[TBL] [Abstract][Full Text] [Related]
12. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
[TBL] [Abstract][Full Text] [Related]
13. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
[TBL] [Abstract][Full Text] [Related]
14. Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma.
Guo Y; Pajovic S; Gallie BL
Biochem Biophys Res Commun; 2008 Oct; 375(1):1-5. PubMed ID: 18644346
[TBL] [Abstract][Full Text] [Related]
15. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
17. Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.
Chi XZ; Kim J; Lee YH; Lee JW; Lee KS; Wee H; Kim WJ; Park WY; Oh BC; Stein GS; Ito Y; van Wijnen AJ; Bae SC
Cancer Res; 2009 Oct; 69(20):8111-9. PubMed ID: 19808967
[TBL] [Abstract][Full Text] [Related]
18. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.
Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A
Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
20. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
